Skip to main content
main-content

Zeitschrift

Medical Oncology

Medical Oncology 3/2011

Ausgabe 3/2011

Inhaltsverzeichnis ( 40 Artikel )

01.09.2011 | Original Paper | Ausgabe 3/2011

The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects

Jian Zhang, Li-Xin Qiu, Shiang-Jiin Leaw, Xi-Chun Hu, Jian-Hua Chang

01.09.2011 | Original Paper | Ausgabe 3/2011

Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience

U. Kefeli, S. Kaya, B. O. Ustaalioglu, A. Bilici, A. U. Kefeli, M. E. Yildirim, M. Seker, B. Yilmaz, T. Salepci, K. Uygun, M. Gumus

01.09.2011 | Original Paper | Ausgabe 3/2011

Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China

Qinghua Deng, Liming Sheng, Dan Su, Lizhen Zhang, Peng Liu, Ke Lu, Shenglin Ma

01.09.2011 | Original Paper | Ausgabe 3/2011

Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis

Jun-Li Liu, Xiao-Yan Wang, Bang-Xing Huang, Fang Zhu, Rui-Guang Zhang, Gang Wu

01.09.2011 | Original paper | Ausgabe 3/2011

Clinical stage of lung cancer revised by accidental pneumothorax and positron emission tomography

Qingliang Xue, Junping Sun, Lina Guo, Jianxin Wang

01.09.2011 | Original Paper | Ausgabe 3/2011

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

Chuan-Yong Mu, Jian-An Huang, Ying Chen, Cheng Chen, Xue-Guang Zhang

01.09.2011 | Original Paper | Ausgabe 3/2011

Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB/IV and benign conditions

Rong Li, Jing Wu, Meili Ma, Jun Pei, Yiyi Song, Xueyan Zhang, Baohui Han

01.09.2011 | Original Paper | Ausgabe 3/2011

The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib

Yuan-Yuan Zhao, Su Li, Yang Zhang, Hong-Yun Zhao, Hai Liao, Ying Guo, Yan-Xia Shi, Wei Jiang, Cong Xue, Li Zhang

01.09.2011 | Original Paper | Ausgabe 3/2011

The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast

Nagehan Ozdemir Barısık, Sevinc Hallac Keser, Aylin Ege Gul, Sibel Sensu, Nilufer Onak Kandemir, Hasan Fehmi Kucuk, Mahmut Gumus, Nimet Karadayı

01.09.2011 | Original Paper | Ausgabe 3/2011

P53 gene polymorphisms and breast cancer risk in Arab women

Shafika Alawadi, Lina Ghabreau, Mervat Alsaleh, Zainab Abdulaziz, Mohamed Rafeek, Nizar Akil, Moussa Alkhalaf

01.09.2011 | Original Paper | Ausgabe 3/2011

Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer

Zhannat Nurgalieva, Chih-Chin Liu, Xianglin L. Du

01.09.2011 | Original Paper | Ausgabe 3/2011

Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?

Gul Basaran, Cabuk Devrim, Hale B. Caglar, Bahadır Gulluoglu, Handan Kaya, Selcuk Seber, Taner Korkmaz, Ferhat Telli, Muharrem Kocak, Faysal Dane, Fulden P. Yumuk, Serdar N. Turhal

01.09.2011 | Original Paper | Ausgabe 3/2011

Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer

Parvin Mehdipour, Marzieh Mahdavi, Javad Mohammadi-Asl, Morteza Atri

01.09.2011 | Original paper | Ausgabe 3/2011

Medullary carcinoma of the breast: a population-based perspective

Steve R. Martinez, Shannon H. Beal, Robert J. Canter, Steven L. Chen, Vijay P. Khatri, Richard J. Bold

01.09.2011 | Original Paper | Ausgabe 3/2011

The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients

Alexandra Giatromanolaki, Efthimios Sivridis, Aliki Fiska, Michael I. Koukourakis

01.09.2011 | Original Paper | Ausgabe 3/2011

Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies

Ezzeldin M. Ibrahim, Abdelaziz Al-Homaidh

01.09.2011 | Original Paper | Ausgabe 3/2011

Dose-dense and dose-intense chemotherapy for small cell ovarian cancer: 2 cases and review of literature

Raj Kumar Shrimali, Peter Denzil Correa, Nick S. Reed

01.09.2011 | Original Paper | Ausgabe 3/2011

Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report

Keiko Shoji, Katsutoshi Oda, Shunsuke Nakagawa, Kei Kawana, Toshiharu Yasugi, Yuji Ikeda, Yutaka Takazawa, Shiro Kozuma, Yuji Taketani

01.09.2011 | Original paper | Ausgabe 3/2011

Expression of phosphatase of regenerating liver-3 in squamous cell carcinoma of the cervix

Yaxi Ma, Baizhou Li

01.09.2011 | Ausgabe 3/2011

Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma

Qin Huang, Qiu-Xia Qu, Fang Xie, Jian-Ming Hu, You-Guo Chen, Xue-Guang Zhang

01.09.2011 | Original Paper | Ausgabe 3/2011

Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer

Xue-Qin Yang, Yan Li, Chuang Chen, Chun-Wei Peng, Shao-ping Liu, Yang Liu

01.09.2011 | Original Paper | Ausgabe 3/2011

Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC)

Yu Yang, Jiang Zhu, Hongfeng Gou, Dan Cao, Ming Jiang, Mei Hou

01.09.2011 | Original Paper | Ausgabe 3/2011

Down-regulation of Dicer in hepatocellular carcinoma

Jin-Feng Wu, Wei Shen, Nian-Zhou Liu, Gui-Li Zeng, Mei Yang, Guo-Qing Zuo, Xiu-Ni Gan, Hong Ren, Kai-Fu Tang

01.09.2011 | Case Report | Ausgabe 3/2011

Gallbladder lymphoma

Srinivas R. Viswanathan, Zain Khalpey, Stanley W. Ashley

01.09.2011 | Ausgabe 3/2011

Anti-cancer effects of 20(S)-protopanoxadiol on human acute lymphoblastic leukemia cell lines Reh and RS4;11

Lihua Sun, Qiong Wang, Xinmin Liu, Nicolaas H. C. Brons, Ning Wang, André Steinmetz, Yali Lv, Yonghong Liao, Huyong Zheng

01.09.2011 | Original Paper | Ausgabe 3/2011

Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis

Jing Wang, Ping Zhan, Jian Ouyang, Bing Chen, Rongfu Zhou, Yonggong Yang

01.09.2011 | Original Paper | Ausgabe 3/2011

Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature

Petros D. Grivas

01.09.2011 | Original Paper | Ausgabe 3/2011

Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy

Li Liu, Renan Chen, Siyong Huang, Yanlan Wu, Guohui Li, Qiang Liu, Dandan Yin, Yingmin Liang

01.09.2011 | Original Paper | Ausgabe 3/2011

Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma

Meng Li, Chunji Gao, Honghua Li, Zhihong Wang, Yongbin Cao, Wenrong Huang, Xiaohong Li, Shuhong Wang, Li Yu, Wanming Da

01.09.2011 | Original paper | Ausgabe 3/2011

Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: an immunohistochemical study

Abdullah Hacıhanefioglu, Emel Gonullu, Ozgur Mehtap, Hakan Keski, Melike Yavuz, Cengiz Ercin

01.09.2011 | Original Paper | Ausgabe 3/2011

Bax expression remains unchanged following antisense treatment directed against BCL-2

Marvin Rubenstein, Courtney M. P. Hollowell, Patrick Guinan

01.09.2011 | Original Paper | Ausgabe 3/2011

Chemotherapy in clear cell sarcoma

Robin L. Jones, Anastasia Constantinidou, Khin Thway, Sue Ashley, Michelle Scurr, Omar Al-Muderis, Cyril Fisher, Cristina R. Antonescu, David R. D’Adamo, Mary Louise Keohan, Robert G. Maki, Ian R. Judson

01.09.2011 | Original Paper | Ausgabe 3/2011

Alterations of telomere length in human brain tumors

Majid Kheirollahi, Masoud Mehrazin, Naser Kamalian, Parvin Mehdipour

01.09.2011 | Original Paper | Ausgabe 3/2011

Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis

Aristeidis Chrysovergis, Vasilios G. Gorgoulis, Ioannis Giotakis, Evangelos Tsiambas, Andreas Karameris, Christos Kittas, Aspasia Kyroudi

01.09.2011 | Original Paper | Ausgabe 3/2011

Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells

Zhenghui Guo, Hai Huang, Lexiang Zeng, Tao Du, Kewei Xu, Tianxin Lin, Chun Jiang, Wen Dong, Yi Cao, Jieqing Chen, WeiDe Zhong, Jian Huang

01.09.2011 | Original paper | Ausgabe 3/2011

Natural products and their role in cancer therapy

David Siu

01.09.2011 | Original Paper | Ausgabe 3/2011

Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats

Yu-Hui Zhang, He Zhang, Jian-min Liu, Zhi-Jian Yue

01.09.2011 | Original Paper | Ausgabe 3/2011

Neuritin expression and its relation with proliferation, apoptosis, and angiogenesis in human astrocytoma

Lei Zhang, Yonggeng Zhao, Cheng-guo Wang, Zhou Fei, Yuan Wang, Lexiang Li, Liang Li, Hai-ning Zhen

01.09.2011 | Original Paper | Ausgabe 3/2011

Determination of clonal status of pulmonary sclerosing hemangioma with X-chromosome inactivation mosaicism and polymorphism of phosphoglycerate kinase and androgen receptor genes

Li Gong, Kai-Xi Ren, Yan-Hong Li, Xiao-Yan Liu, Wen-Dong Zhang, Li Yao, Shao-Jun Zhu, Xiu-Juan Han, Li Zhang, Miao Lan, Wei Zhang

01.09.2011 | Ausgabe 3/2011

Role of human papillomavirus in the development of urothelial carcinoma

Dilek Yavuzer, Nimet Karadayi, Taflan Salepci, Huseyin Baloglu, Ahmet Bilici, Dilek Sakirahmet

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise